Pokmon Card Market Surges Nostalgia HighProfile Sales and Speculation Drive Collectible Frenzy World Bank Data Suggests Automation Could Threaten 69 of Jobs in India MalaysiaJapan Hydrogen Project Scales Back Amid Funding Challenges Nvidia Stock Approaches Critical Technical Level Market Watchers Eye Potential Breakout or Pullback SpaceX Scrubs Starship Test Flight Targets Friday for Debut of Upgraded V3 Rocket Beyond Inc to Acquire Buy Buy Baby Brand Reunite with Bed Bath Beyond RPC Inc RES Q1 2026 Earnings EPS Beats Estimates by 186 Shares Edge Lower ENI SpA E Q1 2026 Earnings Earnings Miss Weighs on Shares as EPS Falls Short of Expectations SIM Q1 2023 Earnings Significant EPS Miss Amid Uncertainty FMC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Challenges EXFY Q1 2026 Earnings EPS Beats Estimates by 68 as Cost Discipline Drives Profitability SOBR Q3 2025 Earnings Reports Loss per Share of 144 Stock Rises 811 Seanergy Maritime SHIP Slides 23 as Dry Bulk Sector Faces Headwinds Support at 1412 in Focus GEN Restaurant Group GENK Faces Selling Pressure Approaches Key Support Level cbdMD Inc YCBD Slightly Lower as Stock Hovers Near Key Support at 071 CMSC Holds Steady Near 2266 CMS Energy Hybrid Notes Attract Income Seekers Amidst Stable Trading OTG Acquisition Corp I OTGA Trading Flat at 1015 Waiting for Merger Catalyst Bath Body Works Reports Q1 Sales Decline and Lower Adjusted Profit Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns SEI Investments SEIC Slides 119 as Stock Approaches Support Zone EDRY Q1 2026 Earnings Significant EPS Miss Amid Challenging Dry Bulk Market ZWS Q1 2026 Earnings EPS Surges Past Estimates with 116 Beat Ashland Q1 2026 Earnings EPS Misses Estimates as Stock Gains Ground CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development Himalaya Shipping Ltd HSHP Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction GEL Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development